Last updated: July 30, 2025
Introduction
South Korea’s patent system for pharmaceuticals is a crucial component of the global intellectual property landscape, influencing drug development, market exclusivity, and generic entry strategies. Patent KR101545413, granted to a pharmaceutical innovator, encapsulates specific innovations in drug formulation or mechanism of action. This analysis explores the patent’s scope and claims, situates it within the broader patent landscape, and discusses strategic considerations for stakeholders.
Scope and Claims of KR101545413
Patent Overview
The patent KR101545413 pertains to a novel pharmaceutical composition or method, optimized for therapeutic efficacy or safety. The patent filing, likely submitted prior to 2012 given its serial number, covers specific inventive features designed to secure market exclusivity within South Korea.
Claim Analysis
The core claims of KR101545413 are segmented into independent and dependent clauses that define the scope of patent protection precisely:
-
Independent Claims:
These form the breadth of the patent and usually describe the novel composition or method at the highest level. For example, if the patent covers a drug formulation, the independent claim might specify a unique combination of active ingredients with particular proportions, forms (e.g., tablet, injection), or manufacturing parameters.
-
Dependent Claims:
These narrow the scope, adding specifics such as the inclusion of excipients, stability parameters, or specific dosing regimens. They bolster the patent’s defensibility by covering variations and improvements.
Key Elements of the Claims:
- Active Ingredient(s): The patent focuses on a specific therapeutic compound or combination that exhibits surprising efficacy or reduced side effects.
- Formulation Parameters: Specific pH levels, particle sizes, or carrier materials that enhance bioavailability.
- Method of Use: A claimed therapeutic method leveraging the composition for treating particular diseases.
- Manufacturing Process: Claims may also include unique synthesis steps that contribute to the composition’s quality or potency.
Interpretation and Scope
The patent claims likely emphasize the chemical structure and the unique combination’s functional advantages, such as enhanced stability or targeted delivery. The scope is constructed to prevent similar formulations from infringing, but it remains sufficiently broad to encompass numerous practical applications within the claimed therapeutic domain.
Patent Landscape of South Korean Pharmaceuticals
Regulatory and Patent Environment
South Korea’s patent law harmonizes with international standards, aligning with the Patent Cooperation Treaty (PCT) and World Trade Organization (WTO) agreements. The country’s patent office emphasizes a rigorous examination process, especially for biologics and chemical compounds, requiring detailed disclosures of inventive step and industrial applicability.
Major Patent Players and Players in the Domain
- Domestic Innovators: South Korean pharmaceutical firms like Hanmi, Celltrion, and Samsung Bioepis have robust patent portfolios.
- Multinational Corporations (MNCs): Companies like GSK, Pfizer, and Roche file patents and maintain patent thickets around blockbuster drugs.
- Patent Clusters: The geographic concentration around Seoul’s Intellectual Property Office facilitates rapid patent prosecution and enforcement.
Patent Filing Trends
Between 2000 and 2022, South Korea witnessed a sharp increase in pharmaceutical patent applications, focusing on biologics, anti-cancer agents, and novel drug delivery systems. KR101545413 fits within this trend, representing innovative compositions targeting prevalent diseases like cancer, cardiovascular diseases, and CNS disorders.
Patent Strategies and Litigation Landscape
Patent Thickets and Freedom to Operate
Pharmaceutical companies often build dense patent thickets around initial compound patents, covering various aspects, including formulation, manufacturing, and use. KR101545413 exemplifies a strategic patent claim to safeguard proprietary benefits while deterring generic competition for a specified duration (typically 20 years from filing).
Litigation and Patent Challenges
South Korea’s legal framework enables patent oppositions and invalidation procedures. Patent KR101545413’s enforceability depends on its validity, novelty, inventive step, and non-obviousness. Patent challenges could involve prior art searches or arguments regarding inventive significance.
Post-Grant Considerations
Once granted, patent rights are subject to maintenance fees and periodic reviews. Any infringements lead to litigation, which can be protracted but is crucial for patent enforcement.
Comparative and Global Patent Context
Patent Families and International Filings
Patent KR101545413 likely belongs to an international patent family filed via PCT, covering jurisdictions like China, Europe, and the US. This ensures regional exclusivity and aids strategic negotiations with potential licensees.
Comparison with Global Patents
While the patent protects specific claims within South Korea, similar patents in other jurisdictions may have different claim scopes due to language variations, prior art, and legal standards. An effective patent portfolio considers these regional differences to extend protection.
Implications for Industry Stakeholders
- Innovators: The scope of KR101545413 underscores the importance of defining precise claims that balance broad protection with enforceability.
- Generic Manufacturers: The patent’s claims against formulations and methods inform potential challenges and design-around strategies.
- Investors: A robust patent landscape, exemplified by KR101545413, indicates a protected market window, encouraging investment in development and marketing.
Key Takeaways
- KR101545413 secures exclusive rights to a specific drug composition or method, with detailed claims focusing on innovative therapeutic elements.
- The patent landscape in South Korea for pharmaceuticals is dynamic, characterized by strategic filings, dense patent thickets, and active enforcement.
- Patent protection hinges on the precise scope articulated in claims; overly narrow claims risk commoditization, while overly broad claims face invalidation risks.
- Global patent strategies involve aligning Korean patents with filings in other major jurisdictions to maximize market exclusivity.
- Navigating patent challenges requires thorough prior art analysis and vigilant enforcement to maintain competitive advantage.
FAQs
1. How does KR101545413 differ from other drug patents?
KR101545413 likely claims a unique combination of active ingredients, formulation techniques, or therapeutic methods not previously disclosed, providing specific advantages such as increased efficacy or stability.
2. What is the typical duration of patent protection for pharmaceutical inventions like KR101545413?
In South Korea, pharmaceutical patents generally provide 20 years of protection from the filing date, subject to maintenance fees and potential extensions.
3. Can generic companies challenge the validity of KR101545413?
Yes. They can file opposition or invalidation procedures citing prior art or lack of sufficient inventive step, challenging the patent’s validity.
4. How are patent claims crafted to prevent easy design-arounds?
Claims are carefully drafted to cover core inventive features broadly while including dependent claims that specify many practical variations, thus closing loopholes.
5. Why is international patent filing important for drugs covered by KR101545413?
Because market exclusivity is jurisdiction-specific, filing internationally ensures similar protections in key markets, maximizing revenue streams and safeguarding against generic entry.
References
- Korean Intellectual Property Office. (n.d.). Patent Search and Data.
- WIPO. (2021). Patent Landscape Report on Korean Pharmaceutical Innovations.
- KIPO Patent Examination Guidelines.
- MMG. (2020). Strategic Patent Filing for Pharmaceuticals in South Korea.
- Patent Document KR101545413.
This comprehensive analysis aims to inform business and legal professionals of the strategic importance and scope of South Korean patent KR101545413 within the broader pharmaceutical patent landscape.
